Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sabby Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2013 | Stem Cell Therapeutics | Post-IPO Equity | 0 |
| 3/2015 | Champions Oncology | Post-IPO Equity | 14M |
| 6/2015 | Ardelyx | Post-IPO Equity | 77.8M |
| 4/2017 | Epic Sciences | Series D | 0 |
| 10/2013 | Arno Therapeutics | Post-IPO Equity | 0 |
| 12/2014 | Naurex | Series C | 0 |
| 8/2014 | Dermira | Series C | 51M |
| 8/2014 | Bellicum Pharmaceuticals | Series C | 55M |
| 9/2022 | RooLife Group | Post-IPO Debt | 1M |
| 1/2015 | Global Blood Therapeutics | Series B | 48M |
| 2/2015 | Cidara Therapeutics | Series B | 42M |
| 4/2014 | Adverum Biotechnologies | Series B | 55M |
| 11/2014 | Blueprint Medicines | Series C | 50M |
| 4/2017 | Epic Sciences | Series D | 0 |
| 6/2015 | Ardelyx | Post-IPO Equity | 0 |
| 3/2015 | Champions Oncology | Post-IPO Equity | 0 |
| 2/2015 | Cidara Therapeutics | Series B | 0 |
| 1/2015 | Global Blood Therapeutics | Series B | 0 |
| 12/2014 | Naurex | Series C | 0 |
| 11/2014 | Blueprint Medicines | Series C | 0 |
| 8/2014 | Bellicum Pharmaceuticals | Series C | 0 |
| 8/2014 | Dermira | Series C | 0 |
| 4/2014 | Adverum Biotechnologies | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
